Could prostate cancer treatment be cut in half?

NCT ID NCT05820633

Summary

This large study aims to see if a shorter, more intense 2-week radiation schedule for the pelvic area is just as effective and safe as the standard 4-5 week schedule for men with prostate cancer that may have spread to nearby lymph nodes. Both groups will also receive a targeted radiation boost to the prostate and hormone therapy. The main goal is to check if the shorter treatment causes similar side effects and controls the cancer just as well, which could save patients significant time and clinic visits.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • BC Cancer Sindi Ahluwalia centre for the Southern Interior

    Kelowna, British Columbia, V1Y 5L3, Canada

  • CHU de Québec - Université Laval

    Québec, G1R 2J6, Canada

  • CISSS de Laval, Hôpital de la Cité-de-la-Santé

    Laval, Quebec, H7M 3L9, Canada

  • CISSS de l'Outaouais, Hôpital de Gatineau

    Gatineau, Quebec, J8P 7H2, Canada

  • CISSS de la Montérégie-Centre, Hôpital Charles-Le Moyne

    Longueuil, Quebec, J4V 2H1, Canada

  • CIUSSS de l'Est-de-l'Île-de-Montréal, Hôpital Maisonneuve-Rosemont

    Montreal East, Quebec, H1T 2M4, Canada

  • CIUSSS de l'Estrie - Centre Hospitalier Universitaire de Sherbrooke (CHUS)

    Sherbrooke, Quebec, Canada

  • CIUSSS du Centre-Ouest-de-l'Île-de-Montréal, Jewish General Hospital

    Montreal, Quebec, H3T 1E2, Canada

  • Carlo Fidani Peel Regional Cancer Centre

    Mississauga, Ontario, L5M 2N1, Canada

  • Cedars Cancer Centre, McGill University Health Centre (MUHC)

    Montreal, Quebec, H4A 3J1, Canada

  • Lakeridge Health Oshawa Cancer centre

    Oshawa, Ontario, L1G 2B9, Canada

Conditions

Explore the condition pages connected to this study.